Dr. Cassandra Natalie Grenade, MD

Dr. Grenade practices at OhioHealth Grady Memorial Hospital in Delaware, Ohio, part of OhioHealth.

Dr. Grenade's NPI, 1770744807, was assigned on June 20, 2008. Dr. Grenade graduated from Ohio State University College of Medicine in 2008. Dr. Grenade holds Ohio license 350999055.

Dr. Grenade's primary practice is OhioHealth Grady Memorial Hospital, at 561 West Central Avenue, Delaware, OH 43015 in Delaware County. The practice phone is (740) 368-5145.

Dr. Grenade's primary practice is OhioHealth Grady Memorial Hospital in Delaware, Ohio, part of OhioHealth. Dr. Grenade is also affiliated with OhioHealth Riverside Methodist Hospital. The medical group on file is OhioHealth Physician Group. Dmand AI also links Dr. Grenade to 3 more hospitals, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Grenade practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Grenade's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Grenade is licensed in Ohio.

CMS data shows 589 Medicare services from Dr. Grenade across 6 procedure codes in 2024, for 236 Medicare patients. Medicare paid $65,742 for them.

CMS counts 236 Medicare patients who saw Dr. Grenade in 2024. The largest group is 65 to 74, with 121 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Grenade's median patient age at 72, with 66% women.

In 2024, Dr. Grenade wrote 1,214 Medicare Part D claims for 243 patients. 83% of them were for generic drugs. CMS names the drug for 971 of them, across 34 drugs with 11 or more claims each, at $1,481,733 in total drug cost. In 2023, CMS named 729 claims across 25 drugs.

Dr. Grenade accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Grenade as offering telehealth.

Dmand AI links 7 papers to Dr. Grenade, published from 2014 to 2024. 2018 was the busiest year, with 3. The most frequent topics are Diet and Socioeconomic Factors. Dr. Grenade has published most often in Nutrients. Dr. Grenade's most frequent co-authors are Aashish D. Bhatt, MD, Dayssy Alexandra Diaz Pardo, MD and Jiaoti Huang, MD, PhD.

CMS Open Payments shows 17 general payments to Dr. Grenade from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 72% of the total. Millennium Pharmaceuticals, Inc. paid the most, $246.

Dr. Grenade graduated from Ohio State University College of Medicine in 2008.